國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 857669      Online Users : 727
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [27/27]
    Conference Papers/Meeting Abstract [5/7]

    Community Statistics


    Item counts issued in 3 years:2(5.88%)
    Items With Fulltext:32(94.12%)

    Download counts of the item
    Download times greater than 0:32(100.00%)
    Download times greater than 100:31(96.88%)
    Total Bitstream Download Counts:13970(0.26%)

    Last Update: 2024-11-28 16:00

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-25 of 34. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2023-09-15 Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers Cancer Research. 2023 Sep 15;83(18):2993-3000.
    2023-03 ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression Cancer Research. 2023 Mar 15;83(6):830-844.
    2021-06-22 A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.] Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
    2021-05-31 A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells Frontiers in Oncology. 2021 May 31;11:Article number 638311.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer Gastric Cancer. 2021 May;24(3):624-639.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] Gastric Cancer. 2021 May;24(3):640-641.
    2020-03-10 Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma Stem Cell Reports. 2020 Mar 10;14(3):462-477.
    2020-02 The multifaceted role of mesenchymal stem cells in cancer Seminars in Cancer Biology. 2020 Feb;60:225-237.
    2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study European Journal of Cancer. 2020 Jan;124:123-130.
    2019-12 The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis Journal of Pathology. 2019 Dec;249(4):498-508.
    2019-11-13 Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc Cancers. 2019 Nov 13;11(11):Article number 1785.
    2019-07 Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers Frontiers in Oncology. 2019 Jul;9:Article number 688.
    2019-05-17 Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling Oncogene. 2019 Feb;38(8):1340-1353.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] Oncogene. 2019 Feb;38(8):1354.
    2018-12 ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness Cancer Science. 2018 Dec;109(Suppl. 2):244.
    2018-11 Targeting PTX3 can prevent drug-resistant cancer progression Protein Science. 2018 Nov;27(Suppl. 1):24.
    2018-10 Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P.
    2017-11 Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
    2017-05 Metronomic chemotherapy: Direct targeting of cancer cells after all? Trends in Cancer. 2017 May;3(5):319-325.
    2016-12 Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988.
    2016-12 NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme Molecular Biology of the Cell. 2016 Dec;27:Meeting Abstract P1160.
    2016-02 Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
    2015-11 Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers Annals of Oncology. 2015 Nov;26:vii106-vii151.
    2015-09 Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers Oncotarget. 2015 Sep;6(27):23987-24001.

    Showing items 1-25 of 34. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback